COMMD9 is highly expressed in NSCLC; COMMD9 promotes cell proliferation, migration, cell cycle G1/S transition, inhibits autophagy, promotes TFDP1/E2F1 transcription activity and inhibits P53 signaling pathway (20). The gene discussed is E2F1; the disease is non-small cell lung carcinoma.